Skip to content

Clinical study on Turmeric mouth wash in the treatment of Oral ulcers due to cancer therapy.

An Open Label, Comparative, Three-Arm, Randomized, Parallel Clinical Study to Evaluate the Efficacy and Safety of Turmeric Oral Rinse in Oral Mucositis during Cancer Chemotherapy and Radiotherapy

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/03/012371
Enrollment
45
Registered
2018-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Subjects with head and neck cancer scheduled to receive chemotherapy or radiotherapy as standard care and with history or prone to develop oral mucositis during cancer chemotherapy or radiotherapy

Interventions

Intervention1: Turmeric oral rinse variant 1: Turmeric oral rinse variant 1 (Turmeric oral rinse with xanthine gum) To be used 10 ml of oral rinse to rinse/swish the mouth for 1 minute four times a d

Sponsors

The Himalaya Drug Company
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Subjects with confirmed histopathologically with head and neck cancer (according to TNM classification) preferably oropharyngeal scheduled to receive chemotherapy or radiotherapy as a standard care. 2 Subjects with history or prone to develop oral mucositis during cancer chemotherapy or radiotherapy. 3 Subjects aged >18 years of either the sex. 4 Subjects willing to give a written informed consent and follow the schedule of the study as per the protocol.

Exclusion criteria

Exclusion criteria: 1 Has participated in a similar clinical investigation in the past four weeks. 2 Severe uncontrolled systemic disorders, diabetes, Hypertension, or genetic and endocrinal disorders. 3 Has used a similar product in the past four weeks. 4 Subjects who refused to sign informed consent. 5 Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Clinical assessment of Mucositis as per the World Health Organisation gradingTimepoint: At entry, end of 1st week, end of 2nd week, end of 3rd week, end of 4th week, end of 5thweek and end of 6thweek

Secondary

MeasureTime frame
Burning sensationTimepoint: At entry, end of 1st week, end of 2nd week, end of 3rd week, end of 4th week, end of 5thweek and end of 6thweek;Difficulty in chewingTimepoint: At entry, end of 1st week, end of 2nd week, end of 3rd week, end of 4th week, end of 5thweek and end of 6thweek;Difficulty in drinkingTimepoint: At entry, end of 1st week, end of 2nd week, end of 3rd week, end of 4th week, end of 5thweek and end of 6thweek;Difficulty in opening the mouthTimepoint: At entry, end of 1st week, end of 2nd week, end of 3rd week, end of 4th week, end of 5thweek and end of 6thweek;Location of ulcersTimepoint: At entry, end of 1st week, end of 2nd week, end of 3rd week, end of 4th week, end of 5thweek and end of 6thweek;Number of ulcersTimepoint: At entry, end of 1st week, end of 2nd week, end of 3rd week, end of 4th week, end of 5thweek and end of 6thweek

Countries

India

Contacts

Public ContactDr Padmanabha

M.S.Ramaiah Hospital

kirthi.koushik@gmail.com09901845412

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026